Trial Profile

Randomized phase III trial of cisplatin + TS-1 [S 1] versus cisplatin + docetaxel regimens for stage IIIB/IV non-small cell lung carcinoma.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
Indications Non-small cell lung cancer
Focus Registrational; Therapeutic Use
Acronyms CATS

Most Recent Events

02 Oct 2012 Final analysis presented at the 37th Congress of the European Society for Medical Oncology.
06 Jun 2012 Status changed from active, no longer recruiting to completed.
06 Jun 2012 Results were reported at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), and in a Taiho Pharmaceutical media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com